IRIS
LUCIANO, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 78
AS - Asia 58
EU - Europa 39
SA - Sud America 3
AF - Africa 1
Totale 179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 78
SG - Singapore 44
CN - Cina 13
FI - Finlandia 10
IT - Italia 7
DE - Germania 6
FR - Francia 5
AT - Austria 3
BR - Brasile 3
IE - Irlanda 2
BE - Belgio 1
CH - Svizzera 1
GB - Regno Unito 1
JP - Giappone 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
SE - Svezia 1
Totale 179
Salva come PNG Salva come JPEG
Città #
Singapore 30
Chandler 22
Helsinki 10
Ashburn 8
Boardman 5
New York 5
Shanghai 5
Springfield 5
Paris 3
São Paulo 3
Dublin 2
Florence 2
Los Angeles 2
Sassari 2
Seattle 2
Amsterdam 1
Benin City 1
Brussels 1
Bucharest 1
Council Bluffs 1
Falkenstein 1
Fort Worth 1
Guangzhou 1
Kunming 1
Milan 1
Nuremberg 1
Oakland 1
Prineville 1
Tokyo 1
Totale 120
Salva come PNG Salva come JPEG
Nome #
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 37
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 32
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 11
A clinical prediction rule for lymphoma development in primary Sjögren's syndrome 8
Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature 8
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study 8
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 7
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 7
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 7
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 6
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 5
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 5
Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials? 5
Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? 5
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 5
Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma 5
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 4
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease 4
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 4
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study 4
The need to ask for directions on the winding road of psoriatic arthritis 4
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study 3
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 3
Imaging in primary Sjögren's syndrome: the 'obsolete and the new' 3
Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis 3
One year in review 2018: novelties in the treatment of rheumatoid arthritis 3
Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome 3
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study 3
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 3
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience 3
Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases 3
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study 3
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 2
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: Consensual US-SG core items definition and reliability 2
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 2
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome 2
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 2
Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives 2
One year in review 2017: novelties in the treatment of rheumatoid arthritis 2
One year in review 2015: Sjögren's syndrome 2
Myositis in primary Sjögren's syndrome: data from a multicentre cohort 2
Totale 232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202352 0 2 4 9 3 6 0 10 11 4 1 2
2023/202435 5 1 6 2 1 7 2 2 0 3 1 5
2024/2025145 35 72 15 16 7 0 0 0 0 0 0 0
Totale 232